Rigorous Evaluation of Drug Repurposing Opportunities
Evaluate & Validate
The Rigorous Evaluation of Drug Repurposing Opportunities involves a systematic and thorough evaluation of potential drug repurposing opportunities, using techniques such as laboratory studies, clinical trials, and observational data.
- Evaluate potential drug repurposing opportunities using a rigorous and systematic approach
- Use a variety of research techniques, including laboratory studies, clinical trials, and observational data
- Validate findings through replication and verification
- Identify potential drug repurposing opportunitiesStart by identifying potential drug repurposing opportunities, using techniques such as literature reviews and database searches.Pro tipLook for areas where existing treatments are not effective or are poorly toleratedWarningBe aware of the potential risks and challenges associated with developing a new treatment
- Evaluate potential drug repurposing opportunities using laboratory studiesUse laboratory studies to evaluate the potential of a drug to treat a new condition, using techniques such as cell culture and animal models.Pro tipUse a variety of research techniques to validate findingsWarningBe aware of the potential limitations and biases of laboratory research
- Validate findings through clinical trials and observational dataTake the findings from laboratory studies and validate them through clinical trials and observational data, using techniques such as randomized controlled trials and cohort studies.Pro tipWork closely with clinicians and patients to ensure that the treatment is effective and safeWarningBe aware of the potential risks and challenges associated with translating laboratory findings into clinical practice
Dr. Fajgenbaum's own experience with Castleman's disease
Dr. Fajgenbaum used the Rigorous Evaluation of Drug Repurposing Opportunities to develop a new treatment for his own Castleman's disease, and has since applied this approach to help other patients.
OutcomeThe development of a new treatment for Castleman's disease, and the improvement of patient outcomes.
Failing to use a rigorous and systematic approach
Failing to use a rigorous and systematic approach to evaluate potential drug repurposing opportunities can lead to inaccurate or incomplete findings.
Not validating findings through replication and verification
Not validating findings through replication and verification can lead to false positives or false negatives.
Dr. Fajgenbaum developed this approach through his own experience with Castleman's disease, and has since applied it to help other patients with rare and debilitating conditions.
Source · PODCAST
How A Doctor Cured His Own Terminal Disease | Dr. David Fajgenbaum